James E. Besser is 10% Owner at FENNEC PHARMACEUTICALS INC. (FENC). They have made 20 open-market trades across 4 companies since 2014, most recently 2025-12-10.
CIK 0001512127
6 open-market purchases totalling $647K since 2014, against 14 sales. Across 5 scored buys the stock is down 3.1% at ninety days, and 7.0 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| FENC | 1,413,694 | $14.1M |
| SNWV | 872,605 | $4.4M |
| PCSA | 1,064,300 | $1.8M |
| MFST | 696,612 | — |
| Total | $20.3M |
Shares reported on the most recent Form 4, priced at the 2025-12-11 close. 1 holding could not be priced and is excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 80% | 20% |
| Avg Move | +8.9% | -0.8% | -3.1% |
| Alpha | +8.8% | -1.5% | -7.0% |
| Scored | 5 | 5 | 5 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 15% | 8% | 100% |
| Avg Move | +11.0% | +1.7% | -19.3% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNWV | SELL | 2025-12-08 | 2025-12-11 | $30.70 | $5.0M | -3.6% | -6.4% | -29.2% |
| PCSA | SELL | 2021-04-06 | 2021-05-05 | $10.78 | $5.2M | -19.1% | -12.6% | -22.6% |
| PCSA | SELL | 2021-02-18 | 2021-02-22 | $11.52 | $574K | -5.8% | +6.6% | -41.8% |
| PCSA | BUY | 2020-10-02 | 2020-10-13 | $4.04 | $121K | -11.1% | -12.1% | +49.9% |
| MFST | BUY | 2019-05-01 | 2019-05-02 | $0.07 | $7K | N/A | N/A | N/A |
| FENC | SELL | 2018-03-28 | 2018-03-29 | $11.50 | $1.7M | +13.9% | +2.0% | -16.4% |
| FENC | SELL | 2018-03-27 | 2018-03-29 | $11.34 | $257K | +13.9% | +2.0% | -16.4% |
| FENC | SELL | 2018-03-22 | 2018-03-29 | $10.76 | $215K | +13.9% | +2.0% | -16.4% |
| FENC | SELL | 2018-03-21 | 2018-03-29 | $10.18 | $2.1M | +13.9% | +2.0% | -16.4% |
| FENC | SELL | 2018-03-20 | 2018-03-29 | $9.70 | $147K | +13.9% | +2.0% | -16.4% |
| FENC | SELL | 2018-03-16 | 2018-03-29 | $9.52 | $61K | +13.9% | +2.0% | -16.4% |
| FENC | SELL | 2018-03-14 | 2018-03-29 | $9.47 | $129K | +13.9% | +2.0% | -16.4% |
| FENC | SELL | 2018-03-13 | 2018-03-29 | $9.27 | $157K | +13.9% | +2.0% | -16.4% |
| FENC | SELL | 2018-03-12 | 2018-03-29 | $9.50 | $176K | +13.9% | +2.0% | -16.4% |
| FENC | SELL | 2018-03-08 | 2018-03-29 | $9.12 | $91K | +13.9% | +2.0% | -16.4% |
| FENC | SELL | 2018-03-08 | 2018-03-29 | $10.11 | $3.1M | +13.9% | +2.0% | -16.4% |
| FENC | BUY | 2016-01-27 | 2018-03-29 | $2.06 | $196K | +13.9% | +2.0% | -16.4% |
| FENC | BUY | 2015-05-27 | 2018-03-29 | $1.65 | $85K | +13.9% | +2.0% | -16.4% |
| FENC | BUY | 2014-12-31 | 2018-03-29 | $2.62 | $59K | +13.9% | +2.0% | -16.4% |
| FENC | BUY | 2014-12-24 | 2018-03-29 | $2.47 | $179K | +13.9% | +2.0% | -16.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 13 | 13 | 13 |